Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

Clinical trial NCT05149768 · RECRUITING

Trial details

NCT number

NCT05149768

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Status

RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2024-02-14

Primary completion

2026-02-14

Enrollment

11

View on ClinicalTrials.gov